Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP

[1]  E. V. van Maarseveen,et al.  Fludarabine and exposure-targeted busulfan compares favorably with busulfan/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  A. Fischer,et al.  Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study , 2014, The Lancet.

[3]  M. Mohty,et al.  Allogeneic hematopoietic stem cell transplantation following reduced‐intensity conditioning regimen in children: a single‐center experience , 2012, European journal of haematology.

[4]  R. Gale,et al.  SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS , 2011, Bone Marrow Transplantation.

[5]  A. Gennery,et al.  Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. , 2011, Blood.

[6]  B. Sandmaier,et al.  Defining the intensity of conditioning regimens: working definitions. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  M. Labopin,et al.  Comparison of Outcomes After Allogeneic HSCT for Adult Patients with AML in Remission Using in the Conditioning Regimen Either I.V. Busulfex (BU) Plus Cyclophosphamide (Cy) or TBI Plus Cy: An- ALWP-EBMT Survey. , 2009 .

[8]  S. Grupp,et al.  Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. , 2009, Blood.

[9]  B. Sandmaier,et al.  Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  G. Federici,et al.  Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia. , 2008, Blood transfusion = Trasfusione del sangue.

[11]  I. Yaniv,et al.  Reduced-intensity conditioning in children: a reappraisal in 2008 , 2008, Bone Marrow Transplantation.

[12]  A. Gratwohl.  Principles of conditioning , 2008 .

[13]  P. Veys,et al.  Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases , 2008, Bone Marrow Transplantation.

[14]  F. Locatelli,et al.  Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood , 2007, Bone Marrow Transplantation.

[15]  H. Ochs,et al.  Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders , 2007, Bone Marrow Transplantation.

[16]  M. Cairo,et al.  Preliminary Results of the Safety of Immunotherapy with Gemtuzumab Ozogamicin following Reduced Intensity Allogeneic Stem Cell Transplant in Children with CD33+ Acute Myeloid Leukemia , 2005, Clinical Cancer Research.

[17]  G. Dini,et al.  The hope and the reality of reduced intensity transplants in children with malignant diseases , 2005, Bone Marrow Transplantation.

[18]  P. Veys,et al.  Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning , 2005, Bone Marrow Transplantation.

[19]  P. Veys,et al.  Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. , 2005, Blood.

[20]  S. Giralt.  Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years? , 2005, Hematology. American Society of Hematology. Education Program.

[21]  W. Tse,et al.  Efficacy of Reduced Intensity Conditioning (RIC) with FLU-BU-ATG and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Pediatric ALL. , 2004 .

[22]  D. Yamashiro,et al.  A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients , 2004, Bone Marrow Transplantation.

[23]  A. Bacigalupo.  Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus , 2004, Bone Marrow Transplantation.

[24]  N. Schmitz,et al.  Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin’s disease , 2004, Annals of Hematology.

[25]  G. Ruiz-Argüelles,et al.  Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  A. Gratwohl,et al.  Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey , 2002, Bone Marrow Transplantation.

[27]  S. Mackinnon,et al.  Reduced intensity conditioning and allogeneic stem-cell transplantation: determining its role in multiple myeloma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  A. Bacigalupo.  Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT) , 2002, Bone Marrow Transplantation.

[29]  A. Bacigalupo.  Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European Group for Blood and Marrow Transplantation (EBMT) , 2000, Bone Marrow Transplantation.

[30]  W. Vaughan.  Reinventing Bone Marrow Transplantation , 1999 .

[31]  R. Champlin,et al.  Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect. , 1999, Oncology.